Tocris-0537

SynDRA canonical compound SYN0952021 — structure-anchored drug synonym record

Clinical phase	Preclinical
Mechanism of action	acetylcholine release enhancer

Mechanisms of action (all sources)

acetylcholine release enhancer

Bioactivity evidence (ChEMBL activities table — not curator-asserted)

MAPT
PTH1R
SMAD3
TDP1
TP53

Cross-references

PubChem CID: 6604731
ChEMBL: CHEMBL1593096
ChEBI: 91621
LINCS BRD: BRD-A30590053

Synonyms

NCGC00024638-01
MR-16728
N-[3-(1-azepanyl)propyl]-2-cyclohexyl-2-phenylacetamide
CS-0020661
N-[3-(azepan-1-yl)propyl]-2-cyclohexyl-2-phenyl-acetamide
BRD-A30590053-003-01-1
BRD-A30590053-003-02-9
MS-33142
SR-01000597759-1
MR16728Hydrochloride
MR 16728 Hydrochloride
NSC-662128
orb1704347
N-[3-(azepan-1-yl)propyl]-2-cyclohexyl-2-phenylacetamide
RefChem:159870
MR 16728
CHEBI:91621
T23015
SR-01000597759
NSC662128
N-(3-(Azepan-1-yl)propyl)-2-cyClohexyl-2-phenylacetamide
mr16728
AKOS024458554
MR-16728 (hydrochloride)
SCHEMBL194768
NCGC00024638-02
starbld0047608

Look up Tocris-0537 in the interactive SynDRA portal →